Wilson Andrew, Chief Executive Officer, sold 9,000 shares of the Electronic Arts Inc. (NASDAQ:EA) in an exchange that happened on January 2nd. The stock was sold at an average price of $79.57 per share, amounting to a transaction worth $716,097. The sale was made public in a document filed with the SEC. Additionally, Chief Studios Officer Miele Laura sold 1,250 shares of this stock in a transaction that took place on January 2nd. The stock was sold at an average price of $79.51 per share, for a total exchange amounting to $99,385. After the transaction, the Chief Studios Officer Miele Laura currently holds 7,411 shares of the company’s stock, which is worth approximately $674475.
With this stock price’s latest movement, it is now -39.83% away from its 1-year high and 23.14% higher than its 1-year low price. In the past seven days, the stock price volatility for Electronic Arts Inc. was 4.25%, whereas its volatility in the past 30 days has been 3.93%. This public company’s stock also has a beta score of 1.12. When the beta value is less/more than 1, it can imply that the stock is less/more volatile than the wider stock market – a metric that traders will surely be keeping tabs on.
Electronic Arts Inc. (NASDAQ:EA) most recently published its quarterly earnings results. The firm posted $0.86 earnings per share (EPS) for the three-month period, surpassing analysts’ consensus estimate of $0.58 by $0.28. The publicly-traded organization reported revenue of $1,222.00 million for the quarter, compared to the average analyst forecast calling for $1,182.92 million, which was surpassing the analyst consensus estimate.
Shares of Electronic Arts Inc. (EA) surged 2.36%, amounting to a gain of $2.1 per share, to finish the regular trading session at $91.01 on Thursday 01/10/2019. After beginning the session at $88.79, shares of Electronic Arts Inc. reached as high as $91.44 during the day, while hitting a 1-day low of $88.52. Trade volume reached 4,713,817 shares against this stock’s average daily volume of 5.11M shares, with a total float of 300.52M. As a consequence of the price increase, Electronic Arts Inc. now has a current market value of 27.76B.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) added 0.00% to its trading price by the close of the most recent session, jumping from its previous closing price of $10.99 to $10.99. This stock decreased in value by -0.45% during the last 7-day period, and experienced a loss of -5.91% over the past 30-day period. In the past three months, this stock’s price lost by -21.56% , and subtracted -29.32% to its price during the last six months of trading. SGMO demonstrated a yearly price loss of -34.97% , while its year-to-date (YTD) price performance has been down -4.27% . This stock’s price changed by +22.11% compared to its 90-day low, and moved down -26.07% comparing to its 90-day high price.
Have a quick look on short, medium and long-term indicators. According to the Composite Indicator, Trendspotter rated the SGMO stock as “Buy”. In the short-term, Sangamo Therapeutics, Inc. (SGMO) has a 20-day average volume of 2,032,195 shares and short-term indicators sets the SGMO stock as “ 80% Sell ” on average basis. In the medium-term, SGMO stock has a 50-Day average volume of 2,025,390 shares and medium-term indicators gave the average rating of “ 75% Sell ”, while in the long-term period the FB stock has a 100-Day average volume of 2,132,118 shares. On average, long-term indicators rated the stock as “67% Sell ”. The overall picture from all short, medium and long-term indicators sets the SGMO stock as “64% Sell ” on average basis.
Recently, multiple brokerages have sent out reports on SGMO. JP Morgan, for example, Downgrade its rating on shares of Sangamo Therapeutics, Inc. from “Overweight ” to a “ Neutral”according to a research note from Wednesday November 14th, 2018. while giving the stock a “ Neutral” from “Buy ” rating, as stated in a research report from Friday, November 9th, 2018. Guggenheim, on the other hand, Initiated a “Buy” rating on this stock in a research note dated Wednesday, October 10th, 2018.
In other news related to Sangamo Therapeutics, Inc. stock, 66.11% shares of SGMO held by institutions. The total number of institutions who held the SGMO shares was 281, according to most recent SEC filling. During the past quarter, total 67,492,004 shares held by institutions with the net change of 1,766,513 shares. In the meantime, 40 new institutions bought the shares of Sangamo Therapeutics, Inc. for the first time and 33 institutions sold all their holdings in the company’s common stock. 133 institutions increased their investment in the SGMO stock and 103 institutions decreased their investment in the Sangamo Therapeutics, Inc. (SGMO)’s stock during the last quarter.